The Clorox Company (NYSE:CLX) Given Average Recommendation of “Reduce” by Brokerages

The Clorox Company (NYSE:CLX) has earned an average rating of “Reduce” from the seventeen analysts that are currently covering the company, Marketbeat reports. Five investment analysts have rated the stock with a sell rating, eleven have given a hold rating and one has assigned a buy rating to the company. The average 12 month price target among brokers that have updated their coverage on the stock in the last year is $103.40.

Several research analysts have recently commented on CLX shares. UBS Group cut their price objective on Clorox from $110.00 to $96.00 and set a “neutral” rating for the company in a report on Friday, May 1st. The Goldman Sachs Group reaffirmed a “sell” rating and issued a $83.00 target price on shares of Clorox in a research note on Friday, May 1st. Wells Fargo & Company dropped their target price on shares of Clorox from $100.00 to $95.00 and set an “equal weight” rating for the company in a research report on Monday, May 18th. Deutsche Bank Aktiengesellschaft reissued a “hold” rating and issued a $91.00 price target on shares of Clorox in a research note on Friday, May 1st. Finally, Zacks Research lowered shares of Clorox from a “hold” rating to a “strong sell” rating in a report on Tuesday, May 12th.

Clorox Price Performance

NYSE:CLX opened at $97.15 on Monday. The firm has a market capitalization of $11.75 billion, a price-to-earnings ratio of 15.77, a P/E/G ratio of 0.46 and a beta of 0.54. Clorox has a 52-week low of $84.70 and a 52-week high of $132.03. The stock has a fifty day moving average of $94.22 and a 200 day moving average of $104.24. The company has a debt-to-equity ratio of 27.03, a quick ratio of 0.65 and a current ratio of 0.84.

Clorox (NYSE:CLX) last announced its earnings results on Thursday, April 30th. The company reported $1.64 earnings per share for the quarter, topping analysts’ consensus estimates of $1.55 by $0.09. Clorox had a return on equity of 443.64% and a net margin of 11.18%.The business had revenue of $1.67 billion for the quarter, compared to analyst estimates of $1.67 billion. During the same period in the prior year, the company earned $1.45 EPS. The company’s quarterly revenue was up .1% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. On average, research analysts expect that Clorox will post 5.61 EPS for the current fiscal year.

Insider Activity

In related news, Director Pierre R. Breber bought 5,000 shares of the business’s stock in a transaction that occurred on Tuesday, May 5th. The stock was bought at an average cost of $85.82 per share, for a total transaction of $429,100.00. Following the completion of the transaction, the director owned 18,000 shares of the company’s stock, valued at approximately $1,544,760. The trade was a 38.46% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 0.63% of the company’s stock.

Institutional Investors Weigh In On Clorox

A number of large investors have recently added to or reduced their stakes in the company. Vermillion & White Wealth Management Group LLC bought a new stake in Clorox during the third quarter worth about $25,000. Caitlin John LLC increased its position in shares of Clorox by 1,807.1% during the 4th quarter. Caitlin John LLC now owns 267 shares of the company’s stock valued at $27,000 after purchasing an additional 253 shares during the last quarter. Darwin Wealth Management LLC purchased a new position in shares of Clorox during the 2nd quarter valued at about $29,000. Vision Financial Markets LLC raised its holdings in shares of Clorox by 166.7% during the 4th quarter. Vision Financial Markets LLC now owns 320 shares of the company’s stock valued at $32,000 after buying an additional 200 shares in the last quarter. Finally, Root Financial Partners LLC lifted its position in Clorox by 83.8% in the 1st quarter. Root Financial Partners LLC now owns 318 shares of the company’s stock worth $33,000 after buying an additional 145 shares during the last quarter. Hedge funds and other institutional investors own 78.53% of the company’s stock.

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.